Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avanti Research
Alabaster, Alabama, United States
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
01
Overview
Avanti Research supplies the world’s broadest portfolio of ultra-pure lipid excipients and custom synthesis services for research, clinical, and commercial use—enabling the first COVID-19 mRNA vaccines and supporting delivery innovation for biopharma, diagnostics, and academic labs globally[1][2][3][4].
- Therapeutic areas
- Other
- Modalities
- Lipid nanoparticle delivery therapySmall molecule (as lipid adjuvants/formulation tools)
- Industry
- Chemicals & Materials
02
Partnerships
LIPID MAPS (exclusive standards partner)[3]Numerous pharma, biotech, vaccine developers (e.g., supported COVID-19 vaccine delivery lipid supply)[2][3]
Beyond the preview
Go deeper on Avanti Research.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Avanti Research.